5 results
To evaluate the effects of LCZ696 compared to valsartan on cognitive function over 3 years in patients with HFpEF as assessed by the CogState cognitive assessment battery.
The primary objectives of this study are:- To demonstrate that LCZ696 is superior to individualized medical therapy for comorbidities in reducing NT proBNP from baseline after 12 weeks of treatment in patients with HFpEF.- To demonstrate that LCZ696…
To compare the antiproteinuric effects of sacubitril/valsartan (ARNI) and valsartan (ARB).
Primary Objective 1:Verfiy that energy can be transmitted from an external unit to the NSM AHLeveeS System, through a wireless connection, resulting in stimulation of the S3 sacral nerve.Primary Objective 2:Confirm that the NSM AHLeveeS System can…
Primary:- To elucidate the change in physical activity as assessed by the distance walked in meters during the 6-minute walk test between baseline and 12weeks of study drug treatment in sacubitril/valsartan vs. enalapril patients.- To assess changes…